These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 1563078)

  • 21. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of growth hormone therapy on the developmental changes of follicle stimulating hormone and insulin-like growth factor-I serum concentrations in Turner's syndrome.
    Bourguignon JP; Gérard A; Deby-Dupont G; Franchimont P
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):85-9. PubMed ID: 8348710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
    Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
    Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
    Reiter JC; Craen M; Van Vliet G
    Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
    Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
    Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF-I resistance and Turner's syndrome.
    Lebl J; Průhová S; Zapletalová J; Pechová M
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):37-41. PubMed ID: 11220703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.
    Malhotra A; Poon E; Tse WY; Pringle PJ; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):393-8. PubMed ID: 8319371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of treatment with growth hormone alone or in combination with oxandrolone in a group of Turner's syndrome children. A preliminary study].
    Cherubini V; Cardinale G; Panfoli C; Pecora R; Lorenzetti L; Bartolotta E
    Minerva Pediatr; 1991 Jun; 43(6):465-9. PubMed ID: 1886533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome.
    Simmons KE
    Pediatrics; 1999 Oct; 104(4 Pt 2):1021-4. PubMed ID: 10506256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone treatment in Turner's syndrome.
    Takano K; Hizuka N; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of short stature and delayed adolescence.
    Wilson DM; Rosenfeld RG
    Pediatr Clin North Am; 1987 Aug; 34(4):865-79. PubMed ID: 3302896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Turner's syndrome with recombinant human growth hormone (somatrem).
    Lippe B; Rosenfeld RG; Hintz RL; Johanson AJ; Frane J; Sherman B
    Acta Paediatr Scand Suppl; 1988; 343():47-52. PubMed ID: 3057808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of 94 patients with Turner's syndrome with recombinant human growth hormone (SM-9500) for two years--the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1989 Aug; 36(4):569-78. PubMed ID: 2684622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
    Gault EJ; Perry RJ; Cole TJ; Casey S; Paterson WF; Hindmarsh PC; Betts P; Dunger DB; Donaldson MD;
    BMJ; 2011 Apr; 342():d1980. PubMed ID: 21493672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.